SALIVARY FLOW-RATES IN PATIENTS WITH HEAD AND NECK-CANCER 0.5 TO 25 YEARS AFTER RADIOTHERAPY

被引：61
|
作者：
LIU, RP
FLEMING, TJ
TOTH, BB
KEENE, HJ
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT DENT ONCOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030
[2] UNIV TEXAS,HLTH SCI CTR,DEPT ORAL DIAGNOST SCI,DENT BRANCH,HOUSTON,TX 77225
来源：
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS | 1990年 / 70卷 / 06期
关键词：
D O I：
10.1016/0030-4220(90)90008-G
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
In this clinical study at the University of Texas M. D. Anderson Cancer Center, unstimulated and stimulated salivary flow rates were obtained from 47 patients with head and neck cancer who had received mantle, unilateral facial, or bilateral facial field radiotherapy from 0.5 to 25 years earlier. The magnitude of salivary flow rate reduction compared with a healthy control group was primarily related to the radiation dosage and the amount of salivary gland tissue included in the irradiated fields. Flow rates were lower for women in all groups, but these differences were not statistically significant. © 1990.
引用
收藏
页码：724 / 729
页数：6
相关论文
共 50 条
  • [21] NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN HEAD AND NECK-CANCER
    GREEN, JA
    BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (728): : 757 - 757
  • [22] CHANGES IN SERUM AND SALIVARY AMYLASE DURING RADIOTHERAPY FOR HEAD AND NECK-CANCER - A COMPARISON OF CONVENTIONALLY FRACTIONATED RADIOTHERAPY WITH CHART
    LESLIE, MD
    DISCHE, S
    RADIOTHERAPY AND ONCOLOGY, 1992, 24 (01) : 27 - 31
  • [23] SEQUENTIAL CHEMOTHERAPY AND RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    STELL, PM
    DALBY, JE
    STRICKLAND, P
    FRASER, JG
    BRADLEY, PJ
    FLOOD, LM
    CLINICAL RADIOLOGY, 1983, 34 (04) : 463 - 467
  • [24] STUDIES WITH BROMODEOXYURIDINE IN HEAD AND NECK-CANCER AND ACCELERATED RADIOTHERAPY
    WILSON, GD
    DISCHE, S
    SAUNDERS, MI
    RADIOTHERAPY AND ONCOLOGY, 1995, 36 (03) : 189 - 197
  • [25] ADJUVANT CHEMOTHERAPY WITH RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    BRADLEY, PJ
    DALBY, JE
    FRASER, JG
    STRICKLAND, P
    STELL, PM
    CLINICAL ONCOLOGY, 1982, 8 (04): : 378 - 378
  • [26] EATING STRATEGIES USED BY PERSONS WITH HEAD AND NECK-CANCER DURING AND AFTER RADIOTHERAPY
    WILSON, PR
    HERMAN, J
    CHUBON, SJ
    CANCER NURSING, 1991, 14 (02) : 98 - 104
  • [27] BIOCHEMICAL MODULATION OF CHEMOTHERAPY AND RADIOTHERAPY IN HEAD AND NECK-CANCER
    WENNERBERG, J
    KJELLEN, E
    LYBAK, S
    RYDELL, R
    PERO, R
    ANTICANCER RESEARCH, 1993, 13 (6B) : 2501 - 2506
  • [28] IMMUNOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER
    VINZENZ, K
    MICKSCHE, M
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1986, 2 (01): : 37 - 49
  • [29] ACCELERATED FRACTIONATION RADIOTHERAPY FOR ADVANCED HEAD AND NECK-CANCER
    LAMB, DS
    SPRY, NA
    GRAY, AJ
    JOHNSON, AD
    ALEXANDER, SR
    DALLY, MJ
    RADIOTHERAPY AND ONCOLOGY, 1990, 18 (02) : 107 - 116
  • [30] MITOMYCIN AND FLUOROURACIL WITH CONCOMITANT RADIOTHERAPY IN HEAD AND NECK-CANCER
    KAPLAN, MJ
    HAHN, SS
    JOHNS, ME
    STEWART, FM
    CONSTABLE, WC
    CANTRELL, RW
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1985, 111 (04) : 220 - 222
12345